Form 8-K - Current report:
SEC Accession No. 0001564590-20-053313
Filing Date
2020-11-12
Accepted
2020-11-12 08:00:21
Documents
3
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-8k_20201112.htm 8-K 30079
2 EX-99.1 rkda-ex991_6.htm EX-99.1 716402
3 GRAPHIC g1fdzcfmirst000001.jpg GRAPHIC 3882
  Complete submission text file 0001564590-20-053313.txt   753118
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 201303447
SIC: 0100 Agricultural Production-Crops